Literature DB >> 26754876

Monitoring multiple sclerosis by multimodal evoked potentials: Numerically versus ordinally scaled scoring systems.

Regina Schlaeger1, Martin Hardmeier1, Marcus D'Souza1, Leticia Grize2, Christian Schindler2, Ludwig Kappos3, Peter Fuhr4.   

Abstract

OBJECTIVE: To compare the ability of different evoked potential scores (EPS) to monitor and predict the disease course in multiple sclerosis (MS).
METHODS: Seventy-two patients with MS or clinically isolated syndrome were investigated by visual, motor, and somatosensory EP and expanded disability status scale (EDSS) at baseline (T0) and months 6, 12, 24, 36 (T4). EP results were rated according to ordinal (o), semi-quantitative (sq), and quantitative (q) EPS. Spearman rank correlation and multivariable linear regression were used to investigate the associations between EPS and clinical disability.
RESULTS: All EPS correlated with EDSS cross-sectionally (0.72⩽rho⩽0.87, all p<0.001) and longitudinally (0.39⩽rho⩽0.47, all p⩽0.004). EPS(T0) and EDSS(T0) together explained 85-86% of EDSS(T4) variance. A posteriori power calculation showed that the sample sizes needed to detect significant changes over 6 months in q-EPS, sq-EPS and o-EPS with 90% certainty would be 50, 129 and 222, respectively. q-EPS change(T1-T0) correlated with EDSS change(T4-T0) (rho=0.56, p<0.001), while sq-EPS and o-EPS changes(T1-T0) did not.
CONCLUSION: All three EPS allow disease course monitoring in MS. However, the quantitative EPS detects clinically relevant short-term changes with a smaller sample size than semi-quantitative or ordinal EPS. SIGNIFICANCE: These results underscore the potential of EPS to characterize MS disease evolution.
Copyright © 2016. Published by Elsevier Ireland Ltd.

Entities:  

Keywords:  Evoked potentials; Monitoring; Multiple sclerosis; Prognosis

Mesh:

Year:  2015        PMID: 26754876     DOI: 10.1016/j.clinph.2015.11.041

Source DB:  PubMed          Journal:  Clin Neurophysiol        ISSN: 1388-2457            Impact factor:   3.708


  8 in total

Review 1.  Remyelination therapies: a new direction and challenge in multiple sclerosis.

Authors:  Jason R Plemel; Wei-Qiao Liu; V Wee Yong
Journal:  Nat Rev Drug Discov       Date:  2017-07-07       Impact factor: 84.694

2.  Motor evoked potentials for multiple sclerosis, a multiyear follow-up dataset.

Authors:  Thijs Becker; Liesbet M Peeters; Jan Yperman; Veronica Popescu; Bart Van Wijmeersch
Journal:  Sci Data       Date:  2022-05-16       Impact factor: 8.501

Review 3.  A new role for evoked potentials in MS? Repurposing evoked potentials as biomarkers for clinical trials in MS.

Authors:  Martin Hardmeier; Letizia Leocani; Peter Fuhr
Journal:  Mult Scler       Date:  2017-05-08       Impact factor: 6.312

4.  Multicentre assessment of motor and sensory evoked potentials in multiple sclerosis: reliability and implications for clinical trials.

Authors:  Martin Hardmeier; François Jacques; Philipp Albrecht; Habib Bousleiman; Christian Schindler; Letizia Leocani; Peter Fuhr
Journal:  Mult Scler J Exp Transl Clin       Date:  2019-05-01

5.  Multimodal Evoked Potentials as Potential Biomarkers of Disease Activity in Patients With Clinically Isolated Syndrome.

Authors:  Edyta Dziadkowiak; Małgorzata Wieczorek; Mieszko Zagrajek; Justyna Chojdak-Łukasiewicz; Ewa Gruszka; Sławomir Budrewicz; Anna Pokryszko-Dragan
Journal:  Front Neurol       Date:  2022-02-08       Impact factor: 4.003

6.  Brain functional connectivity analysis in patients with relapsing-remitting multiple sclerosis: A graph theory approach of EEG resting state.

Authors:  Sepehr Shirani; Maryam Mohebbi
Journal:  Front Neurosci       Date:  2022-09-09       Impact factor: 5.152

7.  Cytotoxic CD4+ T Cells Drive Multiple Sclerosis Progression.

Authors:  Liesbet M Peeters; Marjan Vanheusden; Veerle Somers; Bart Van Wijmeersch; Piet Stinissen; Bieke Broux; Niels Hellings
Journal:  Front Immunol       Date:  2017-09-20       Impact factor: 7.561

8.  Evolution of tongue somatosensory evoked potentials in people with multiple sclerosis.

Authors:  Magdalena Krbot Skorić; Luka Crnošija; Berislav Ruška; Tereza Gabelić; Barbara Barun; Ivan Adamec; Mario Habek
Journal:  Mult Scler Relat Disord       Date:  2020-06-07       Impact factor: 4.339

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.